Squar Milner Financial Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,214
Closed -$204K 64
2020
Q2
$204K Buy
1,214
+151
+14% +$23.7K 0.12% 204
2020
Q1
$139K Hold
1,063
0.08% 211
2019
Q4
$158K Buy
+1,063
New +$146K 0.08% 243
2019
Q3
Sell
-1,063
Closed -$150K 385
2019
Q2
$150K Hold
1,063
0.1% 203
2019
Q1
$160K Sell
1,063
-60
-5% -$8.63K 0.12% 193
2018
Q4
$139K Buy
1,123
+33
+3% +$4.51K 0.13% 179
2018
Q3
$173K Buy
1,090
+789
+262% +$119K 0.16% 177
2018
Q2
$42K Buy
+301
New +$41.3K 0.04% 360

Other funds holding FBT

Squar Milner Financial Services's FBT Position: Q3 2020 in Review

Squar Milner Financial Services sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2020, closing a stake of 1,214 shares — an estimated $204K sold.

Squar Milner Financial Services first reported a position in FBT in Q2 2018 and held it in 8 quarters. The position peaked at $204K in Q2 2020. 213 funds tracked by Wall St. Rank hold FBT as of Q3 2020.

  • Squar Milner Financial Services reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 1,214 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2020, an estimated $204K.
  • Squar Milner Financial Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2018 and held it in 8 quarters.
  • Squar Milner Financial Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $204K in Q2 2020.
  • 213 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2020.

Based on Squar Milner Financial Services's 13F filing for Q3 2020.